Tech Company Financing Transactions

Rafagen Funding Round

Rafagen secured a $75 thousand financing round on 3/31/2009. Investors included TEDCO.

Transaction Overview

Company Name
Announced On
3/31/2009
Transaction Type
Venture Equity
Amount
$75,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
9700 Great Seneca Hwy. 191
Rockville, MD 20850
USA
Email Address
Not Recorded
Overview
RAFAGEN's primary focus is on the development and commercialization of next generation gene expression systems, with applications in solving the most challenging problems in molecular therapeutics.
Profile
Rafagen LinkedIn Company Profile
Social Media
Rafagen Company Twitter Account
Company News
Rafagen News
Facebook
Rafagen on Facebook
YouTube
Rafagen on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Hahm Sung-Ho
  Hahm Sung-Ho LinkedIn Profile  Hahm Sung-Ho Twitter Account  Hahm Sung-Ho News  Hahm Sung-Ho on Facebook


 

 

Browse more venture capital transactions:

Prev: 3/31/2009: Biotectix venture capital transaction
Next: 3/31/2009: UpWind Solutions venture capital transaction

 

Share this article

 


About Our VC Transactions Data

We record every notable VC transaction. All VC database entries reported here are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary